PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Intas & Accord signs Agreement to acquire Prothya Biosolutions
AHMEDABAD, India , Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire 100% of Prothya Biosolutions Belgium ...
2025-08-11T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development
RICHMOND, VA . , Aug. 11, 2025 /PRNewswire/ -- In the field of pediatric development, a significant advancement is taking shape. For years, parents have navigated a marketplace of nutritional aids ...
2025-08-11T    Biotechnology   Health Care/Hospital 
Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
HYDERABAD, India , Aug. 11, 2025 /PRNewswire/ -- Caliber, a leading global provider of GxP-compliant digital solutions for the life sciences industry, proudly announces the start of its 25th year ...
2025-08-11T    Computer Software   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
EVERISE STRENGTHENS LEADERSHIP TEAM WITH CHIEF REVENUE OFFICER AND CHIEF FINANCIAL OFFICER APPOINTMENTS
PLANTATION, Fla. , Aug. 11, 2025 /PRNewswire/ -- Everise, a global leader in transforming customer experiences, today announced two senior leadership appointments as the company continues its growth ...
2025-08-11T    Computer/Electronics   Health Care/Hospital 
REVEALING STUDY HAS REJUVANT LEADING THE LONGEVITY PACK
Renowned Longevity Researcher Reveals Highlights of New Study to NBJ Conference Guests ...
2025-08-11T    Health Care/Hospital   Medical/Pharmaceuticals 
AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs
— Novel non-cytolytic injectable drug targets submental fat with significantly reduced pain and swelling — Phase 3 clinical trial underway in South Korea , following strong safety and efficacy results ...
2025-08-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
"Senior Speed Stack" Introduces Emerging Sport Stacking to Help Reduce Cognitive Decline in the Elderly
Key Points: ...
2025-08-11T    Health Care/Hospital   Sports 
Turtlebrace is now available through SPS and at Hanger Clinics Across the U.S.
MONTRÉAL , Aug. 11, 2025 /PRNewswire/ -- We're thrilled to announce that Turtlebrace will now be available through SPS , the largest supplier of orthotics and prosthetics (O&P) componentry ...
2025-08-11T    Computer/Electronics   Health Care/Hospital   Medical Equipment 
Everest Medicines to Announce 2025 Interim Results on August 29, 2025
SHANGHAI , Aug. 11, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ...
2025-08-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules
WuXia293 Stable  platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules. WuXia293 ...
2025-08-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.